Abstract
Introduction

97
Scorpionism is considered a serious public health threat and was officially The symptomatology of scorpionism involves local pain, which can be 107 associated with nausea, sweating, tachycardia, fever, and stirring. Moderate TsV hyaluronidase activity was first demonstrated by Possani' 
192
The tested samples were TsV (2 µg) and TsV neutralized with anti- NaBH 4 solution in 0.1 mol/l NaOH (1 mg/ml) was prepared. The pH was adjusted 200 to 7.4 using 1 mol/l NaOH. Next, 25 μl of TsV (5 g/l in saline 0.9% w/v) was added,
201
and vacuum was applied to the vial, followed by addition of 0.1 ml of Na 99m TcO 4
202
(3.7 MBq). The solution was kept at room temperature for 15 min. into the right tight of healthy Swiss mice (6-8 weeks old, 24-28 g; n = 6 per group).
226
Mice were anesthetized with a mixture of xylazine (15 mg/kg) and ketamine (80 227 mg/kg), and an incision was made in the animals' tails for blood collection in pre- In the turbidimetric assays, commercial hyaluronidase from bovine testis 290 exhibited high hyaluronidase activity, which was referred to as 100% activity
291
(positive control). Ultra-pure water had no enzyme activity, which was referred to 292 as 0% activity (negative control). TsV presented high enzymatic activity, similar 293 to that observed for the commercial hyaluronidase (positive control) and was 294 considered to be 100% active (Fig. 1 ). In the in vitro neutralization assay, pre-295 incubation of TsV with anti-hyaluronidase serum completely neutralized 296 hyaluronidase activity (Fig. 1) .
297
Figure 1. In vitro neutralization assay using rabbit anti-hyaluronidase serum.
298
Hyaluronidase activity (%) was measured using a turbidimetric assay. Commercial hyaluronidase 299 from bovine testis was used as a positive control, and ultrapure water was used as a negative 300 control. TsV (2 µg) was incubated with anti-hyaluronidase serum (Anti-Hyal, 10 µl) for 1 h at 37°C 301 before testing. Anti-hyaluronidase serum neutralized 100% of the hyaluronidase activity in TsV.
302
All values are expressed as the mean ± S.E. The radiolabeling stability curve for 99m Tc-TsV is shown in Fig. 2 . Stability at all times evaluated. Noteworthy, the labeled neutralized TsV remained at the 347 site of injection (right tight muscle) (Fig. 4B) .
348
Regarding the kinetics of TsV spreading, high levels of 99m Tc-TsV diluted 349 in PBS were absorbed by the organs, particularly the kidneys and bladder ( 
359
Images are pseudocolored according to the color scale. by a decrease in blood concentration (Fig. 6) , corroborating the results previously 401 observed in the blood clearance assay (Fig. 3) . On the other hand, animals (Fig. 3, 4A and 5). After that time, the level of TsV decreases in the 445 organs (Fig. 5) and increases in the kidneys (Fig. 4A, 5 ), thus indicating a renal 
361
Neutralization of hyaluronidase delays biodistribution of TsV to
465
In the present work, we observed that the inhibition of hyaluronidase in hyaluronidase administration time, when compared to the control group (Fig. 6 ).
495
These results corroborated the 99m Tc-TsV biodistribution assays previously 496 neutralized with anti-hyaluronidase serum, which showed that the maximum 497 concentration of TsV detected in tissues occurs 240 min after injection (Fig. 5 ).
498
Thus, aiming at using hyaluronidase neutralization as a first-aid treatment, our access from the sting/bite site to the bloodstream (Fig. 3, 4) but is also involved 513 in the biodistribution of TsV from the blood to the organs (Fig. 5, 6 ). TsV from the blood to the tissues. of TsV toxins through the victim's body and is pivotal in the envenoming process.
528
Since we have proved the critical role of hyaluronidase in scorpionism, our 529 findings lead the way for new therapeutic strategies. 
